Obesity and obesity-associated disorders pose a major public health issue worldwide. Apart
from conventional weight loss drugs, next-generation probiotics (NGPs) seem to be very …

Antioxidants have drawn the attention of the scientific community due to being related to the
prevention of various degenerative diseases. The antioxidant capacity has been extensively …

Unlike the bacterial microbiome, the role of early-life gut fungi in host metabolism and
childhood obesity development remains poorly characterized. To address this, we …

Recent studies have demonstrated the effect of probiotics, prebiotics, and synbiotics on
adiponectin and leptin levels; however, those findings remain contested. The present study …

Probiotic products in various formulations are widely used world-wide for a seemingly
limitless range of indications––from health maintenance to the alleviation of common …

Obesity, type 2 diabetes mellitus (T2DM) and non-alcoholic fatty liver disease (NAFLD) are
three common metabolic diseases with high prevalence worldwide. Emerging evidence …

Abstract Glucagon-like peptide 1 (GLP-1), a gastrointestinal peptide and central mediator of
glucose metabolism, is secreted by L cells in the intestine in response to food intake …

Obesity is often accompanied by low-grade chronic inflammation and metabolic syndrome. It
has been established that microbiota influences many physiological processes, including …

Despite the early recognition of obesity as an epidemic with global implications, research on
its pathogenesis and therapeutic approach is still on the rise. The literature of the 21st …

Metabolic syndrome (MetS) is characterized by complex metabolic changes involving a
cluster of co-occurring conditions, such as abdominal obesity, high blood pressure, high …